Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01SAT
|
|||
| Former ID |
DAP000897
|
|||
| Drug Name |
Bevantolol
|
|||
| Synonyms |
Bevantololum; Bevantolol [INN:BAN]; Bevantololum [INN-Latin]; (+-)-bevantolol; 1-((2-(3,4-Dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)-2-propanol; 1-((2-(3,4-dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)-2-propanol; 1-(3,4-Dimethoxyphenethylamino)-3-(m-tolyloxy)-2-propanol; 1-(3,4-dimethoxyphenethylamino)-3-m-tolyloxy-propan-2-ol; 1-[2-(3,4-Dimethoxy-phenyl)-ethylamino]-3-m-tolyloxy-propan-2-ol; 1-[2-(3,4-dimethoxyphenyl)ethylamino]-3-(3-methylphenoxy)propan-2-ol; 1-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-3-(3-methylphenoxy)propan-2-ol
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Hypertension [ICD-11: BA00-BA04] | Approved | [1], [2] | |
| Therapeutic Class |
Antihypertensive Agents
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H27NO4
|
|||
| Canonical SMILES |
CC1=CC(=CC=C1)OCC(CNCCC2=CC(=C(C=C2)OC)OC)O
|
|||
| InChI |
1S/C20H27NO4/c1-15-5-4-6-18(11-15)25-14-17(22)13-21-10-9-16-7-8-19(23-2)20(12-16)24-3/h4-8,11-12,17,21-22H,9-10,13-14H2,1-3H3
|
|||
| InChIKey |
HXLAFSUPPDYFEO-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 59170-23-9
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
421943, 4422032, 8151591, 14952538, 29221540, 46506014, 50023137, 50749008, 57321288, 85220220, 85431913, 96099850, 103292500, 104300401, 127079310, 128127039, 134338174, 135144541, 136948561, 137149322, 142059896, 160964610, 162173227, 163693492, 163853213, 168287480, 172861635, 179150476, 224982727, 226433399, 250218234, 251916825, 251918064, 252455906
|
|||
| ChEBI ID |
CHEBI:238698
|
|||
| SuperDrug ATC ID |
C07AB06
|
|||
| SuperDrug CAS ID |
cas=059170239
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. | |||
| REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 3 | Determination of bevantolol in human plasma by high performance liquid chromatography using solid phase extraction technique. Arch Pharm Res. 2007 Jul;30(7):890-7. | |||
| REF 4 | Different changes of plasma membrane beta-adrenoceptors in rat heart after chronic administration of propranolol, atenolol and bevantolol. Life Sci. 2007 Jul 12;81(5):399-404. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.